A testable framework integrates platelet engineering and injectable hydrogels with CAR T cells for localized treatment of microscopic residual disease after breast cancer surgery
Farshad Heydari, Mohammed S. Alqassimi, Nasrin Mansuri, Mehdi Derakhshani, Michael R Hamblin, Jalal Naghinezhad
Springer Nature ·
2026-11-02
· DOI 10.1186/s11671-026-05095-3
The publisher did not provide an abstract — full text is available via the link below.
Farshad Heydari, Mohammed S. Alqassimi, Nasrin Mansuri, Mehdi Derakhshani, Michael R Hamblin, Jalal Naghinezhad. A testable framework integrates platelet engineering and injectable hydrogels with CAR T cells for localized treatment of microscopic residual disease after breast cancer surgery. // Discover Nano. – 2026. – DOI: 10.1186/s11671-026-05095-3. – URL: https://doi.org/10.1186/s11671-026-05095-3
Farshad Heydari, Mohammed S. Alqassimi, Nasrin Mansuri, Mehdi Derakhshani, Michael R Hamblin, & Jalal Naghinezhad (2026). A testable framework integrates platelet engineering and injectable hydrogels with CAR T cells for localized treatment of microscopic residual disease after breast cancer surgery. Discover Nano. https://doi.org/10.1186/s11671-026-05095-3
Farshad Heydari, et al. “A testable framework integrates platelet engineering and injectable hydrogels with CAR T cells for localized treatment of microscopic residual disease after breast cancer surgery.” Discover Nano, 2026. doi:10.1186/s11671-026-05095-3.
@article{Heydari2026,
title = {A testable framework integrates platelet engineering and injectable hydrogels with CAR T cells for localized treatment of microscopic residual disease after breast cancer surgery},
author = {Heydari, Farshad and Alqassimi, Mohammed S. and Mansuri, Nasrin and Derakhshani, Mehdi and Hamblin, Michael R and Naghinezhad, Jalal},
journal = {Discover Nano},
year = {2026},
doi = {10.1186/s11671-026-05095-3},
url = {https://doi.org/10.1186/s11671-026-05095-3}
}